StudyFinder

Clear

Search Results Within Category "Pain, Physical Rehabilitation, and Palliative Care"

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

Search all categories
3 Study Matches

Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury (VRWalk)

Hannah Palanchi - hannah.palanchi@vcuhealth.org

Trost, Zina
NCT05005026
HM20020719
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• The study will recruit individuals with complete injury (American Spinal Injury Association [ASIA] classification A) with lumbar, paraplegic, or low tetraplegic (C5-C7) injury. Additional criterial will include:
• persistent NP symptoms that are of daily severity of at least 4/10
• endorsement of more than 2 items on a 7-item Spinal Cord Injury Pain Instrument, SCIPI
• age of 18 - 65
• more than one-year post-injury
Exclusion Criteria:

• Not meeting injury type criteria
• Not meeting NP criteria
• Age 17 or less
• Less than a year following injury
• Inability to comprehend spoken English
• Prisoners
Other: VR Game 1, Other: VR Game 2
Spinal Cord Injuries, Neuropathic Pain
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Virginia Commonwealth University Richmond, Virginia

Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy

Autumn Lanoye, PhD - lanoyeam@vcu.edu

Hong, Susan
NCT05259527
HM20023717
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Diagnosis of stage I-III cancer of any type, OR diagnosis of stage IV cancer being treated with curative intent * Receiving or scheduled to begin taxane-based chemotherapy at Virginia Commonwealth University (VCU) Health Massey Comprehensive Cancer Center * Vitamin D serum level \<20 ng/mL Note: study participants with Vitamin D serum level ≥20 ng/mL may be enrolled in the observational arm.
Exclusion Criteria:
* Pre-existing diagnosis of neuropathy * Currently taking prescription Vitamin D (ergocalciferol) * Inability to converse in English * Pregnancy * Chronic kidney disease (stage IV or greater) * Known hyperparathyroidism * Hypercalcemia: Calcium levels \>10.5 mg/dL Note: study participants with calcium levels \<10.5 mg/dL may be enrolled in the observational arm.
DRUG: Ergocalciferol Capsules, DIETARY_SUPPLEMENT: Cholecalciferol Capsules
Neuropathic Pain
Neuropathic pain, Neuropathy, Vitamin-D
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Virginia Commonwealth University Richmond, Virginia Autumn Lanoye, PhD - (autumn.lanoye@vcuhealth.org) Susan Hong, MD - (susan.hong@vcuhealth.org)

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain (PRESENCE)

Steffi Siebert, MPH - presencestudy@pitt.edu

NCT06374238
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• Aged 16 to 30 years of age at time of enrollment
• Sickle Cell Disease diagnosis of any genotype based on referral or documentation
• Reports chronic pain (≥4 days/week for past 3 months or more) OR A) Being prescribed pain medication to be taken (≥4 days/week for past 3 months or more) OR B) Taking pain medication (≥4 days/week for past 3 months or more) OR C) Receiving non-pharmaceutical pain treatment (≥4 days/week for past 3 months or more)
• Access to an iOS or Android mobile device with internet access
Exclusion Criteria:

• Unable to speak or read English
• Prior hematopoietic stem cell transplant for sickle cell disease
BEHAVIORAL: CBT+ Health coach, BEHAVIORAL: CBT w/o Health Coach ( self-guided), BEHAVIORAL: Usual Care
Pain, Sickle Cell Disease
Sickle Cell Disease, Pain management, Cognitive Behavioral Therapy, Wellness
I'm interested
Share via email
Show 13 locations

Study Locations

Hide all locations
Location Contacts
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois Kevin Guerrero - (kguerrero@lueriechildrens.org)
Children's Healthcare of Atlanta Atlanta, Georgia Katyria Thornton - (katyria.thornton@choa.org) Vontarius Howard Jesse - (vontarius.howard@choa.org)
Connecticut Children's Medical Center Hartford, Connecticut Christopher Theriault - (ctheriault@connecticutchildrens.org)
Rutgers New Jersey Medical School Newark, New Jersey Kim White - (whiteka@rwjms.rutgers.edu)
The Regents of the University of Michigan Ann Arbor, Michigan Anela Mukherjee - (mukherja@med.umich.edu)
UCLA Mattel Children's Hospital Ronald Reagan Hospital Los Angeles, California Debbie Argueta Rufino - (darguetarufino@mednet.ucla.edu)
UPMC Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania Alex Berkebile - (berkebileak@upmc.edu) Amy Travis - (travisam@upmc.edu)
UPMC University of Pittsburgh Classical Hematology Adult Clinic Pittsburgh, Pennsylvania Steffi Siebert, MPH - (presencestudy@pitt.edu)
University of Rochester Medical Center Rochester, New York Priya Kaushal - (priya_kaushal@urmc.rochester.edu)
University of South Alabama Medical Center Mobile, Alabama Jessica King - (jlking@health.southalabama.edu) T'Shemika Perryman - (tperryman@health.southalabama.edu)
Virginia Commonwealth University Richmond, Virginia Danie Sop, PhD - (daniel.sop@vcuhealth.org)
Wake Forest Baptist Hospital Durham, North Carolina Julie Fountain - (Julie.Fountain@Advocatehealth.org)
Weil Cornell Medical College New York, New York Masiel Infante - (mai4011@med.cornell.edu)